Intervention

AMXI-5001:Dose Expansion Phase II

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting1

Common conditions6

Lead sponsors shown1

Clinical trials

1 shown

A Trial of AMXI-5001 for Treatment in Patients With Advanced MalignanciesNCT04503265 · 2020-08-12

RECRUITING

Common conditions

Advanced Malignant Neoplasm1 Breast Cancer1 Homologous Recombination Deficiency1 Ovarian Cancer1 Pancreatic Cancer1 Prostate Cancer1

Leading sponsors

AtlasMedx, Incorporated1

Trial status mix

RECRUITING1

Phase mix

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.